Future research is needed to clarify the pathogenicity of CRHR1 genetic variations and underlying mechanisms of cognitive impairment in COVID-19 survivors and explore potential therapeutic strategies targeting both genetic and psychological factors. This evidence concerns the gene CRHR1 and Cognitive impairment.